Latest News about BNTX
Recent news which mentions BNTX
The 3 Best Bargain Stocks to Buy in Q2 2024
March 31, 2024
From InvestorPlace
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
From InvestorPlace
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
From Benzinga
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
March 20, 2024
From Benzinga
Tickers
BNTX
From InvestorPlace
Why Is BioNTech Stock Trading Lower On Wednesday?
March 20, 2024
From Benzinga
US Stock Futures Stall As Traders Await Fed Chair Powell's Decision; Analyst Sees S&P 500 Showing 'Signs Of Near-Term Top'
March 20, 2024
From Benzinga
Earnings Scheduled For March 20, 2024
March 20, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
From InvestorPlace
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
From InvestorPlace
It’s Time! 3 Dodgy Pharma Stocks to Sell in February
March 04, 2024
From InvestorPlace
5 Value Stocks In The Healthcare Sector
March 04, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For BioNTech
February 20, 2024
Tickers
BNTX
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 12, 2024
From Benzinga
3 Blue-Chip Stocks to Buy at a 52-Week Low in February
February 07, 2024
From InvestorPlace
3 Pharma Stocks to Sell in February Before They Crash and Burn
February 02, 2024
From InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
From Benzinga
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
January 25, 2024
From InvestorPlace
From Benzinga
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
January 17, 2024
From Benzinga
BioNTech Prepares To Be Commercial Ready By 2025, Revenue Growth Expected To Return In 2025
January 09, 2024
From Benzinga
P/E Ratio Insights for BioNTech
January 09, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.